These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22027220)

  • 1. Molecular characterization of EP6--a novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibitor.
    Wisniewska JM; Rödl CB; Kahnt AS; Buscató El; Ulrich S; Tanrikulu Y; Achenbach J; Rörsch F; Grösch S; Schneider G; Cinatl J; Proschak E; Steinhilber D; Hofmann B
    Biochem Pharmacol; 2012 Jan; 83(2):228-40. PubMed ID: 22027220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
    Hieke M; Rödl CB; Wisniewska JM; la Buscató E; Stark H; Schubert-Zsilavecz M; Steinhilber D; Hofmann B; Proschak E
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1969-75. PubMed ID: 22326163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.
    Fischer L; Steinhilber D; Werz O
    Br J Pharmacol; 2004 Jul; 142(5):861-8. PubMed ID: 15197110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LO.
    Buscató El; Wisniewska JM; Rödl CB; Brüggerhoff A; Kaiser A; Rörsch F; Kostewicz E; Wurglics M; Schubert-Zsilavecz M; Grösch S; Steinhilber D; Hofmann B; Proschak E
    Future Med Chem; 2013 May; 5(8):865-80. PubMed ID: 23682565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate is a potent inhibitor of 5-lipoxygenase.
    Pergola C; Jazzar B; Rossi A; Buehring U; Luderer S; Dehm F; Northoff H; Sautebin L; Werz O
    J Pharmacol Exp Ther; 2011 Jul; 338(1):205-13. PubMed ID: 21447614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).
    Hofmann B; Steinhilber D
    Expert Opin Ther Pat; 2013 Jul; 23(7):895-909. PubMed ID: 23600432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
    Barzen S; Rödl CB; Lill A; Steinhilber D; Stark H; Hofmann B
    Bioorg Med Chem; 2012 Jun; 20(11):3575-83. PubMed ID: 22551629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the search for novel 5-lipoxygenase inhibitors.
    Steinhilber D; Hofmann B
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):70-7. PubMed ID: 23953428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors.
    Fischer L; Szellas D; Rådmark O; Steinhilber D; Werz O
    FASEB J; 2003 May; 17(8):949-51. PubMed ID: 12670876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid.
    Werz O; Greiner C; Koeberle A; Hoernig C; George S; Popescu L; Syha I; Schubert-Zsilavecz M; Steinhilber D
    J Med Chem; 2008 Sep; 51(17):5449-53. PubMed ID: 18710209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of 5-lipoxygenase inhibitors--lessons from cellular enzyme regulation.
    Werz O; Steinhilber D
    Biochem Pharmacol; 2005 Aug; 70(3):327-33. PubMed ID: 15907806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.
    Safayhi H; Mack T; Sabieraj J; Anazodo MI; Subramanian LR; Ammon HP
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1143-6. PubMed ID: 1602379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase.
    Meirer K; Rödl CB; Wisniewska JM; George S; Häfner AK; Buscató EL; Klingler FM; Hahn S; Berressem D; Wittmann SK; Steinhilber D; Hofmann B; Proschak E
    J Med Chem; 2013 Feb; 56(4):1777-81. PubMed ID: 23356879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin.
    Werz O
    Planta Med; 2007 Oct; 73(13):1331-57. PubMed ID: 17939102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
    Gupta N; Nicholson DW; Ford-Hutchinson AW
    Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
    Delorme D; Ducharme Y; Brideau C; Chan CC; Chauret N; Desmarais S; Dubé D; Falgueyret JP; Fortin R; Guay J; Hamel P; Jones TR; Lépine C; Li C; McAuliffe M; McFarlane CS; Nicoll-Griffith DA; Riendeau D; Yergey JA; Girard Y
    J Med Chem; 1996 Sep; 39(20):3951-70. PubMed ID: 8831761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
    Rask-Madsen J; Bukhave K; Laursen LS; Lauritsen K
    Agents Actions; 1992; Spec No():C37-46. PubMed ID: 1359745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
    Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Bode ML; Gravestock D; Moleele SS; van der Westhuyzen CW; Pelly SC; Steenkamp PA; Hoppe HC; Khan T; Nkabinde LA
    Bioorg Med Chem; 2011 Jul; 19(14):4227-37. PubMed ID: 21700466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.